Health Care/Hospital
XtalPi -Enabled PharmaEngine PEP08 Achieves Enrollment Milestone, with Second Synthetic Lethality Program Underway
SHENZHEN, China, May 4, 2026 /PRNewswire/ -- XtalPi (2228.HK), a leading AI- and robotics-powered innovation platform, today announced dual breakthroughs in its strategic partnership with PharmaEngine (4162.TWO) PEP08, a next-generation PRMT5 inhibitor discovered via XtalPi's platform, has succes...
2026-05-04 08:19
139th Canton Fair Phase 3 Advances Toward a Better Life with New and Strengthened Product Zones
GUANGZHOU, China, May 3, 2026 /PRNewswire/ -- The 139th China Import and Export Fair (Canton Fair) has rolled out nine newly established product zones. Phase 3 features an expanded and upgraded Intelligent Healthcare zone and the inaugural presentation of a Functional & Technical Fabrics zone. ...
2026-05-03 18:45
1552
Restore Vision Announces First-in-Human Clinical Interim Results for RV-001, a GPCR-Based Optogenetic Gene Therapy
* Phase I/II clinical trial interim results, out to 168 days, from the two RV-001 dosing cohorts with advanced Retinitis Pigmentosa are presented at key May 2026 meetings: Eyecelerator and Retinal Therapeutics Innovation Summit. * No dose-limiting toxicities (DLTs) or drug-related serious adve...
2026-05-01 14:30
7147
TLX101-Px (Pixlumi®) MAA Accepted in Europe
MELBOURNE, Australia and INDIANAPOLIS, May 1, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the marketing authorization application (MAA) filed in Europe for TLX101-Px (O-(2-[18F]fluoroethyl)-L-tyrosine, 18F-FET), its glioma (brain cancer...
2026-05-01 08:48
4186
TraceLink Wins 2026 Globee® Cybersecurity Award as OPUS Sets the Standard for Secure, Agentic Supply Chain Operations
GxP-aligned, industrial-grade platform secures the world's largest Agentic Business Network—enabling trusted, real-time execution across global supply chains Summary TraceLink has been named a winner in the 2026 Globee® Awards for Cybersecurity, recognizing the company's leadership in securing c...
2026-04-30 22:00
3131
Park Systems Launches NX1: The Highest Resolution AFM for Atomic-Scale Imaging in Ambient Conditions
GWACHEON, South Korea, April 30, 2026 /PRNewswire/ -- Park Systems Corp., the world's leading provider of atomic force microscopy (AFM) solutions, today announced the launch of the NX1 — a compact, high-performance AFM that delivers atomic resolution imaging in ambient conditions. Developed in co...
2026-04-30 20:44
2078
Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis
- Bambusa's lead product candidate, BBT001 is a next-generation long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-31 for the treatment of atopic dermatitis (AD) and other type 2 inflammatory skin diseases - - Bambusa plans to announce topl...
2026-04-30 20:00
2097
For the Reasons that Matter: A First‑of‑Its‑Kind Multi-Country Campaign Spotlights Adult Respiratory Health
A first-of-its-kind multi-country adult respiratory health awareness campaign is now live across Singapore, Malaysia, Indonesia, and the Philippines SINGAPORE, April 30, 2026 /PRNewswire/ -- In conjunction with World Immunisation Week, Pfizer Singapore, together with healthcare professionals, ha...
2026-04-30 18:53
2759
Malaysia Healthcare Strengthens Presence in Myanmar as Demand for Trusted Treatment Abroad Grows
KUALA LUMPUR, Malaysia, April 30, 2026 /PRNewswire/ -- For many patients in Myanmar, seeking medical care abroad is becoming an increasingly considered decision, particularly for specialised treatments, second opinions, and long-term health management. As healthcare awareness grows, more patients...
2026-04-30 16:43
3144
Huahui Health and BeOne Medicines Enter into a Global Exclusive Option, License and Collaboration Agreement for Innovative Oncology Drug HH160
BEIJING, April 30, 2026 /PRNewswire/ -- Huahui Health today announced that it has entered into a global exclusive option, license and collaboration agreement with BeOne Medicines for HH160, a novel trispecific antibody in oncology immunotherapy. Under the agreement, BeOne Medicines is granted an ...
2026-04-30 16:28
3815
For the Reasons that Matter: A First‑of‑Its‑Kind Multi-Country Campaign Spotlights Adult Respiratory Health
MAKATI CITY, Philippines, April 30, 2026 /PRNewswire/ -- Pfizer Philippines, together with healthcare professionals, has launched "For the Reasons that Matter", a public awareness campaign focused on adult respiratory health. Rolling out across the Philippines, Malaysia, Indonesia and Singapore, ...
2026-04-30 16:14
3837
Ascendion Recognized Among India's Top 50 Best Workplaces in Health & Wellness for the Third Consecutive Year
BENGALURU, India, April 30, 2026 /PRNewswire/ -- Ascendion, an AI-native
software engineering company, has been recognized among the Top 50 ofIndia's
Best Workplaces™ in Health & Wellness 2026: Companies That Care, marking its
third consecutive year on the list.
2026-04-30 15:54
3415
Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases
SINGAPORE and TAIPEI, April 30, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. ("Formosa", 6838.TW) and the Singapore Eye Research Institute ("SERI") are pleased to announce a strategic research collaboration to develop next-generation ophthalmic formulations. This partnership will leverage ...
2026-04-30 14:30
3249
New Classification System of Malocclusions Published in the Journal of Aligner Orthodontics (JAO) by Prof. Gang Shen's Team
SHANGHAI, April 30, 2026 /PRNewswire/ -- A seminal research paper titled "A New Classification System for Malocclusions with Facial Convexity"has been officially published in the 2026 Volume 1 issue of the Journal of Aligner Orthodontics (JAO). This article, authored by Professor Gang Shen and hi...
2026-04-30 13:33
2390
Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine
HONG KONG and HANGZHOU, China, April 30, 2026 /PRNewswire/ -- Hangzhou Diagens Biotech Co., Ltd. (HKEX: 2526, "Diagens"), a pioneer in medical imaging foundation models, today announced its first annual results since its listing. The report marks a pivotal milestone in the company's transition fr...
2026-04-30 13:18
3931
Haier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025
AI-powered growth surges as Haier Biomedical scales from product coverage to premium brand leadership, building a global life science tools and intelligent productivity platform QINGDAO, China, April 30, 2026 /PRNewswire/ -- Haier Biomedical (688139.SH), a global leader in life sciences and medi...
2026-04-30 12:35
2901
2026 ESMO GC | Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations
SHANGHAI, April 30, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, today announced that two latest clinical study results of its novel Nectin‑4 targeting ADC (R&D code: 9MW2821) in cervical cancer will be ...
2026-04-30 12:26
2114
D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types
Elisrasib monotherapy demonstrates notable efficacy in three major tumor types at its recommended phase 2 dose (RP2D, 600 mg QD). Phase 2 clinical outcomes include: * 2L+ KRAS G12Ci–naïve NSCLC: ORR of 58.8%, mPFS of 12.2 months * 2L+ colorectal cancer (CRC): ORR of 46.9%, mPFS of 9.5 months ...
2026-04-30 11:20
3044
CMEF 2026 wraps up in Shanghai: a global stage for medical breakthroughs and future trends
SHANGHAI, April 30, 2026 /PRNewswire/ -- The 93rd China International Medical Equipment Fair (CMEF), together with its concurrent industry events, has successfully concluded on April 12 at the National Exhibition and Convention Center (Shanghai) after four days of exhibitions and exchanges. Under...
2026-04-30 10:26
1932
Taimei Technology Debuts at BioKorea 2026, Showcasing AI-Powered Clinical Research Solutions
SEOUL, South Korea, April 30, 2026 /PRNewswire/ -- Taimei Technology, a leading AI-driven drug clinical development platform, made its first public appearance in South Korea at BioKorea 2026, drawing significant attention with its advanced AI-powered clinical research technology solutions. Headq...
2026-04-30 10:00
2318
Week's Top Stories
Most Reposted
HKBU Symphony Orchestra Annual Gala Concert to integrate digital technology and artificial intelligence
[Picked up by 306 media titles]
2026-04-27 21:47
Amadeus outlines intention to acquire Idemia Public Security (IPS) for €1.2 billion, to create seamless end-to-end travel journeys of the future
[Picked up by 300 media titles]
2026-04-29 14:31Agoda and TPO Launch MOU to Unlock Opportunities at the City Level
[Picked up by 292 media titles]
2026-04-28 11:00
Hong Leong Bank Vietnam Named Best SME Bank for Customer Experience in Southeast Asia and Vietnam
[Picked up by 288 media titles]
2026-04-28 17:50
Nokia, Blaize, and Datacomm Diangraha Unite to Deliver Hybrid AI Inference Across Indonesia and Southeast Asia
[Picked up by 281 media titles]
2026-04-28 18:00
Most Read
SC Joins Forces with "Thai Longstay Management" to Elevate Thailand as a World-Class Living Destination, offering Exclusive Long Stay Visa Privileges for Condo Buyers to Cater to Global Citizens
2026-05-01 18:00
7205
Delixy Holdings Limited Reports Fiscal Year 2025 Financial Results
2026-05-01 04:30
6830
CNFinance Files Annual Report on Form 20-F for Fiscal Year 2025
2026-05-01 04:35
6559